Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
IMPORTANCE: Neuromyelitis optica spectrum disorders (NMOSD) can present with very similar clinical features to multiple sclerosis (MS), but the international diagnostic imaging criteria for MS are not necessarily helpful in distinguishing these two diseases. OBJECTIVE: This multicentre study tested...
Main Authors: | Juryńczyk, M, Tackley, G, Kong, Y, Geraldes, R, Matthews, L, Woodhall, M, Waters, P, Kuker, W, Craner, M, Weir, A, DeLuca, G, Kremer, S, Leite, M, Vincent, A, Jacob, A, de Sèze, J, Palace, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2016
|
Similar Items
-
Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
by: Jurynczyk, M, et al.
Published: (2016) -
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease.
by: Jurynczyk, M, et al.
Published: (2017) -
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
by: Jurynczyk, M, et al.
Published: (2017) -
RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
by: Elsone, L, et al.
Published: (2014) -
AQP4 antibody assay sensitivity comparison in the era of the 2015 diagnostic criteria for NMOSD
by: Prain, K, et al.
Published: (2019)